Treatment of chronic ocular hypotony with intraocular application of sodium hyaluronate

British Journal of Ophthalmology

Volumn 93, Issue 2, 2009, Pages 235-239

  Kucukerdonmez C ^a   Beutel, J ^b   Bartz Schmidt, K U ^b   Gelisken, F ^b,c  

^a BASKENT UNIVERSITY   (Turkey)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOROID MELANOMA; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENUCLEATION; EYE INJURY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INJECTION SITE INFLAMMATION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; MEDICAL RECORD REVIEW; MORPHOLOGY; PENETRATING TRAUMA; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA TRANSLOCATION; RETINA SURGERY; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITRECTOMY; DRUG EFFECT; DRUG SCREENING; INJECTION; MIDDLE AGED; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RETINA; VITREOUS BODY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DRUG EVALUATION; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPOTENSION; POSTOPERATIVE COMPLICATIONS; RETINA; RETROSPECTIVE STUDIES; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY; YOUNG ADULT;

EID: 60849127585     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.143834     Document Type: Article

References (24)

1. Fine HF, Biscette O, Chang S, et al. Ocular hypotony: a review. Compr Ophthalmol Update 2007;8:29-37.
2. Kim HC, Hayashi A, Shalash A, et al. A model of chronic hypotony in the rabbit. Graefes Arch Clin Exp Ophthalmol 1998;236:69-74.
3. Oyakhire JO, Moroi SE. Clinical and anatomical reversal of long-term hypotony maculopathy. Am J Ophthalmol 2004;137:953-5.
4. O'Connell SR, Majji AB, Humayun MS, et al. The surgical management of hypotony. Ophthalmology 2000;107:318-23.
5. Jonas JB, Vossmerbaeumer U, Kamppeter BA. Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 2004;82:637.
6. Ugahary LC, Ganteris E, Veckeneer M, et al. Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma. Am J Ophthalmol 2006;141:571-3.
7. Friedman SM, Mahootchi A. The use of intravitreal gas for the treatment of ocular hypotony after glaucoma filtration surgery. Ophthalmic Surg Lasers Imaging 2006;37:234-5.
8. Takaya K, Suzuki Y, Nakazawa M. Four cases of hypotony maculopathy caused by traumatic cyclodialysis and treated by vitrectomy, cryotherapy, and gas tamponade. Graefes Arch Clin Exp Ophthalmol 2006;244:855-8.
9. Kurtz S, Leibovitch I. Combined perfluoropropane gas and viscoelastic material injection for anterior chamber reformation following trabeculectomy. Br J Ophthalmol 2002;86:1225-7.
10. Kirchhof B. Retinectomy lowers intraocular pressure in otherwise intractable glaucoma: preliminary results. Ophthalmic Surg 1994;25:262-7.
11. Laurent UB, Fraser JR. Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit. Exp Eye Res 1983;36:493- 503.
12. Widder W. Animal experiments on the duration of retention of different vitreous body implants. Graefes Arch Clin Exp Ophthalmol 1962;164:550-69.
13. Denlinger JL, El-Mofty AA, Balazs EA. Replacement of the liquid vitreus with sodium hyaluronate in monkeys. II. Long-term evaluation. Exp Eye Res 1980;31:101-17.
14. Gerke E, Meyer-Schwickerath G, Wessing A. Healon in retinal detachment with proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1984;221:241-3.
15. Kloti R. Hyaluronic acid as vitreous body replacement. Ophthalmologica 1972;165:351-9.
16. Altangerel U, Rai S, Fontanarosa J, et al. Intracameral 2.3% sodium hyaluronate to treat postoperative hypotony in patients with glaucoma. Ophthalmic Surg Lasers Imaging 2006;37:106-11.
17. Joussen AM, Walter P, Jonescu-Cuypers CP, et al. Retinectomy for treatment of intractable glaucoma: long term results. Br J Ophthalmol 2003;87:1094-102.
18. Daniele S, Schepens CL. Can chronic bulbar hypotony be responsible for uveal effusion? Report of two cases. Ophthalmic Surg 1989;20:872-5.
19. Koerner F, Niesel P, Konig H. Inflow and outflow relations after intraocular fluid-Healon exchange in a case of chronic ocular hypotension. Int Ophthalmol 1985;8:261-6.
20. Cadera W, Harding PW, Gonder JR, et al. Management of severe hypotony with intravitreal injection of Healon. Can J Ophthalmol 1993;28:236-7.
21. Tosi GM, Schiff W, Barile G, et al. Management of severe hypotony with intravitreal injection of viscoelastic. Am J Ophthalmol 2005;140:952-4.
22. Lewis H, Aaberg TM, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol 1991;111:8-14.
23. Nuyts RM, Greve EL, Geijssen HC, et al. Treatment of hypotonous maculopathy after trabeculectomy with mitomycin C. Am J Ophthalmol 1994;118:322-31.
24. Binkhorst CD. Inflammation and intraocular pressure after the use of Healon in intraocular lens surgery. J Am Intraocul Implant Soc 1980;6:340-1.